Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FXANG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,394
Award facts
- Contract value 100% obligated
- $85,393.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $85,393.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count units) on September 26, 2025, with a completion date of September 29, 2025. This competitive award, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's primary IDC vehicle with DLA functions as a comprehensive global pharmaceutical support mechanism, enabling supply of critical medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Otezla, a prescription medication used in the treatment of psoriasis and psoriatic arthritis, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FXANG?
SPE2DB25FXANG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXANG worth?
The government has obligated $85,394 on SPE2DB25FXANG.
Is contract SPE2DB25FXANG an order under another contract?
Yes. SPE2DB25FXANG is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXANG competed?
The extent of competition for SPE2DB25FXANG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award